SOPHiA GENETICS SA (SOPH)
SOPHiA GENETICS SA Statistics
Share Statistics
SOPHiA GENETICS SA has 66.83M shares outstanding. The number of shares has increased by 2.23% in one year.
| Shares Outstanding | 66.83M |
| Shares Change (YoY) | 2.23% |
| Shares Change (QoQ) | 2.23% |
| Owned by Institutions (%) | 27.11% |
| Shares Floating | 52.29M |
| Failed to Deliver (FTD) Shares | 2.82K |
| FTD / Avg. Volume | 3.57% |
Short Selling Information
The latest short interest is 61.76K, so 0.09% of the outstanding shares have been sold short.
| Short Interest | 61.76K |
| Short % of Shares Out | 0.09% |
| Short % of Float | 0.12% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -3.25 and the forward PE ratio is -4.75. SOPHiA GENETICS SA's PEG ratio is 0.15.
| PE Ratio | -3.25 |
| Forward PE | -4.75 |
| PS Ratio | 3.11 |
| Forward PS | 1 |
| PB Ratio | 2.1 |
| P/FCF Ratio | -3.98 |
| PEG Ratio | 0.15 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for SOPHiA GENETICS SA.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.71, with a Debt / Equity ratio of 0.31.
| Current Ratio | 3.71 |
| Quick Ratio | 3.49 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | -0.59 |
| Debt / FCF | -0.59 |
| Interest Coverage | -34.8 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $154.07K |
| Profits Per Employee | $-147.74K |
| Employee Count | 423 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 3.62 |
Taxes
| Income Tax | 1.22M |
| Effective Tax Rate | -2% |
Stock Price Statistics
The stock price has increased by -41.77% in the last 52 weeks. The beta is 1.02, so SOPHiA GENETICS SA's price volatility has been higher than the market average.
| Beta | 1.02 |
| 52-Week Price Change | -41.77% |
| 50-Day Moving Average | 3.41 |
| 200-Day Moving Average | 3.64 |
| Relative Strength Index (RSI) | 43.91 |
| Average Volume (20 Days) | 78.95K |
Income Statement
In the last 12 months, SOPHiA GENETICS SA had revenue of 65.17M and earned -62.49M in profits. Earnings per share was -0.95.
| Revenue | 65.17M |
| Gross Profit | 43.94M |
| Operating Income | -66.57M |
| Net Income | -62.49M |
| EBITDA | -50.76M |
| EBIT | -59.36M |
| Earnings Per Share (EPS) | -0.95 |
Balance Sheet
The company has 80.23M in cash and 30.03M in debt, giving a net cash position of 50.2M.
| Cash & Cash Equivalents | 80.23M |
| Total Debt | 30.03M |
| Net Cash | 50.2M |
| Retained Earnings | -440.28M |
| Total Assets | 155.31M |
| Working Capital | 72.6M |
Cash Flow
In the last 12 months, operating cash flow was -42.82M and capital expenditures -8.18M, giving a free cash flow of -51M.
| Operating Cash Flow | -42.82M |
| Capital Expenditures | -8.18M |
| Free Cash Flow | -51M |
| FCF Per Share | -0.77 |
Margins
Gross margin is 67.42%, with operating and profit margins of -102.14% and -95.89%.
| Gross Margin | 67.42% |
| Operating Margin | -102.14% |
| Pretax Margin | -94.01% |
| Profit Margin | -95.89% |
| EBITDA Margin | -77.89% |
| EBIT Margin | -102.14% |
| FCF Margin | -78.25% |
Dividends & Yields
SOPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for SOPH is $6.5, which is 124.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.5 |
| Price Target Difference | 124.1% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Scores
| Altman Z-Score | -2.3 |
| Piotroski F-Score | 2 |